Suggestions
Reed McClung
Vice President, US Multiple Myeloma Marketing, Hematology at Bristol-Myers Squibb
Reed McClung is an experienced pharmaceutical executive with over 30 years of commercial experience and 25 years of pharmaceutical leadership across multiple functions.2 He currently serves as the Executive Vice President of Oncology Business Development at Eagle Pharmaceuticals, Inc., a position he has held since July 2022.13
Prior to his current role, Reed McClung worked at Bristol-Myers Squibb as the Vice President of US Multiple Myeloma Marketing, Hematology from November 2019 to May 2022.3 His career in the pharmaceutical industry includes significant experience in oncology and hematology, spanning over 16 years with companies such as Novartis, Celgene, and Bristol-Myers Squibb.2
Some key points about Reed McClung's career:
- He led the $12B multiple myeloma franchise at Celgene/BMS before joining Eagle Pharmaceuticals.2
- At Celgene, he held positions as Head of US Multiple Myeloma Marketing and Executive Director of Multiple Myeloma Marketing.3
- He spent 13 years at Novartis in various roles of increasing responsibility in both Canada and the U.S., including Sr. Director of Customer Marketing Oncology Managed Markets US.3
Reed McClung earned his Bachelor of Science degree in Biology from Mount Allison University in New Brunswick, Canada, between 1986 and 1990.13